While both the mouse and human tumors show strong expression of mature luminal cell differentiation signatures and activation of several pathways, mouse microacinar tumors also show activation of Erbb2 signaling, which is traditionally associated with the Her-2 enriched subtype of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.